I concur with what the noble Lord, Lord Willis of Knaresborough, just said. All of the research councils and charities support these amendments. There are the caveats to which he referred, particularly related to clinical trials and data. There is another important issue about the summary given at the conclusion of the research, which not only has to protect the confidentiality of the patients but also needs to be brief, because otherwise it is too cumbersome. On the whole, these amendments that we debated long and hard are most welcome.
Care Bill [HL]
Proceeding contribution from
Lord Patel
(Crossbench)
in the House of Lords on Monday, 21 October 2013.
It occurred during Debate on bills on Care Bill [HL].
Type
Proceeding contribution
Reference
748 c854 
Session
2013-14
Chamber / Committee
House of Lords chamber
Subjects
Librarians' tools
Timestamp
2013-12-20 04:36:45 +0000
URI
http://hansard.intranet.data.parliament.uk/Lords/2013-10-21/13102134000123
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2013-10-21/13102134000123
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2013-10-21/13102134000123